Navigation Links
OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent
Date:12/1/2009

ent," said Dr. Thambar. "This innovative technology potentially represents the next generation of coronary stents."

The Combo Stent is designed to combine the pro-healing technology used in OrbusNeich's Genous(TM) Bio-engineered R stent(TM) for rapid endothelial coverage with an abluminal sirolimus drug elution for the control of neointimal proliferation. The low dose sirolimus elution is accomplished through the use of the SynBiosys(TM) biodegradable polymer matrix from SurModics, Inc. ( SRDX).

"The pre-clinical work has shown the effectiveness of combining the endothelial progenitor cell capture technology to promote endothelialization coupled with the low dose, abluminal sirolimus elution to regulate hyperplasia," said Ian T. Meredith, M.B.B.S., Ph.D., Professor of Cardiology, Director of MonashHeart and Executive Director of the Monash Cardiovascular Research Centre, Melbourne, Australia, one of the trial's principal investigators. The other principal investigators are Stephan Windecker, M.D., director of invasive cardiology at the University Hospital Bern in Switzerland, and Alexandre Abizaid, M.D., Ph.D., director of the catheterization laboratory at the Institute Dante Pazzanese of Cardiology in Sao Paulo, Brazil. "The Combo Stent could be the best of both world's approach for patients at the highest risk of restenosis," Meredith added.

"The Combo Stent has demonstrated significantly lower neointimal hyperplasia, improved endothelial coverage relative to commercially available drug-eluting stents and lower presence of inflammation and foreign body reaction in multiple pre-clinical studies," said Renu Virmani, M.D., president and medical director of CVPath Institute, Inc. "Furthermore, I have long believed that the next generation of stents can benefit from biodegradable polymers. The data I've seen on the SynBiosys biodegradable polymer suggest it is very biocompatible with low inflammatory scores that could also resul
'/>"/>

SOURCE OrbusNeich
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Data from Patient Subsets of e-HEALING, a Worldwide Registry, Support Use of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) as Alternative to Drug- Eluting Stents
2. 5,000 Patients Treated With OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) Now Enrolled in Real-Life Use Global Registry
3. OrbusNeich Receives CE Mark Approval for Sapphire(TM) 1.25MM PTCA Dilatation Catheter
4. Symposium at Angioplasty Summit TCT Asia Pacific 2008 Features OrbusNeichs Genous(TM) Bio-engineered R stent(TM)
5. OrbusNeich Receives Approval to Market Genous(TM) Bio-engineered R stent(TM) in Taiwan
6. OrbusNeich Receives CE Mark Approval for Scoreflex(TM) Coronary Dilatation Catheter
7. OrbusNeich Files Patent Infringement Lawsuit Against Boston Scientific
8. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
9. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
10. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
11. HEI, Inc. Announces Sale of RFID Division Assets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... Illinois researcher says that the cornerstone of our efforts ... people to participate in the Supplemental Nutrition Assistance Program ... SNAP, formerly known as the Food Stamp Program, is ... additional improvements could be even more successful at reducing ... of I professor of agricultural and consumer economics and ...
(Date:5/22/2013)... of up to 1,000 mg per day can help ... author was Lisa Langsetmo, a Ph.D. Research Associate at ... Goltzman, Division of Endocrinology and Metabolism in the Department ... in the Musculoskeletal Disorders axis at the Research Institute ... published in the Journal of Clinical Endocrinology & ...
(Date:5/22/2013)... parents are married are less likely to be obese, ... University of Houston. , "Childhood obesity is a significant ... of all U.S. children ages 2-17 overweight or obese," ... at Rice and director of Rice,s Kinder Institute Urban ... conducted to explore the impact of family structure on ...
(Date:5/22/2013)... 22, 2012 (Hackensack, NJ) John Theurer Cancer Center at ... 50 cancer centers, will bring together leading cancer experts, ... implications of cell therapy and interventional immunology in oncology, ... , "I,m excited to bring together some of the ... and implications of cell therapies in oncology, both in ...
(Date:5/22/2013)... Garcinia cambogia select is a dual action fat ... extra fat being stored in the body. For a rapid ... fat burner helps people in this regard by making the ... it does this by secreting a hormone serotonin which makes ... from emotional overeating. In this way, it keeps a control ...
Breaking Medicine News(10 mins):Health News:Alleviating hunger in the US -- researcher says, it's a SNAP 2Health News:Alleviating hunger in the US -- researcher says, it's a SNAP 3Health News:Calcium supplements linked to longer lifespans in women 2Health News:Children of married parents less likely to be obese 2Health News:Children of married parents less likely to be obese 3Health News:Progress after recent breakthrough which opened new chapter in anti-cancer cell therapies 2Health News:Garcinia Cambogia Reviews Released Online for Fast Weight Loss Solution with Offer of Extra 3 Month Supply 2
... A researcher at Tulane University, Marie Krousel-Wood says people ... taking blood pressure medications than others. And people who ... report less intake of BP drugs. ,‘Nationally ... high blood pressure have the condition under control. Poor ...
... quota in Central educational institutions, Union Health Minister Ambumani ... media creation // and that the government's decision ... resistance was all by the media,' Ramadoss told newspersons ... the government proposal, he said 'This is in accordance ...
... cases of jaundice were detected here today even as ... to be suffering from the disease. // ... Nagar found four persons including two children were suffering ... the civil surgeon visited the area as doctors collected ...
... time women will have a vaccine to protect themselves from ... of 'Gardasil' produced by American pharmaceutical giant Merck. // ... of the vaccine, Gardasil, for use in girls and women ... allows an early release of products with potential to provide ...
... Recent research has revealed that taking antibiotics for three days ... is equally effective in the treatment of common pneumonia // ... to curb the rising problem of antibiotic-resistant bacteria, ... diseases at the Academic Medical Center, in Amsterdam said,’The question ...
... state and federal, experts warn that many million dollars ... // . ,A psychiatrist, Ian Hickie says ... were having clash in setting policies. ,The ... due to lack of clear accountability, federal-state role in ...
Cached Medicine News:Health News:Pneumonia Effectively Treated with Short-Term Antibiotic Course 2
(Date:5/22/2013)... Z-Medica, a leading developer and marketer of ... line of products designed to meet the unique needs ... EMS 4x4 Dressing, QuikClot ® EMS TraumaPad ... all custom-designed to help responders stop bleeding fast and ... a hospital or trauma center. The line includes products ...
(Date:5/22/2013)... , May 22, 2013 MEDIFIRST SOLUTIONS, ... to update shareholders about some recent company developments. As ... its avenues of communication with shareholders. Integrating social media ... a Facebook page and will post updates on Twitter.  ... hashtag is #medifirstusa. Says CEO ...
(Date:5/22/2013)... , May 22, 2013  Flagship Ventures, a ... on healthcare and sustainability, today announced the appointment ... a Senior Partner. In this role, Mr. Bancel ... companies. In addition to working closely ... also serves as President and Chief Executive Officer ...
Breaking Medicine Technology:Z-Medica Launches New Line of Hemostatic Agents for use in Emergency Medical Services 2Medifirst Solutions, Inc. Announces Update To Shareholders 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 3
... Nov. 18 Starpharma Holdings Limited (ASX: SPL; OTCQX: ... of A$15.6 million through a private placement to institutional ... approximately A$24 million. , The lead investor in the ... highly regarded institutional fund manager. As a result ...
... , SAN DIEGO, Nov. 18 Rules-Based Medicine, Inc. ... and services agreement with Covance Inc. (NYSE: CVD ... powerful combination of biomarker technologies and services for use in ... RBM as its exclusive third-party provider of multiplexed protein biomarker ...
Cached Medicine Technology:Starpharma Announces $15.6 million Capital Raising 2Starpharma Announces $15.6 million Capital Raising 3Rules-Based Medicine Forms Biomarker Alliance With Covance Inc. 2Rules-Based Medicine Forms Biomarker Alliance With Covance Inc. 3
... IM3300 EDTV Autoclavable 3CCD Video System, our newly ... truly innovative design features. Operation of the LS7500 ... to operate. To improve the safety of the ... which allows an extra layer of control before ...
Ambion's barrier tips prevent cross-contamination of samples by means of an aerosol filter. They are RNase- and DNase-free and are ideal for handling RNA, PCR applications, and for working with radio...
1000 L, Bulk Recommended for 500 and 1000 L pipettes...
Conducting disposable filter-tips....
Medicine Products: